Literature DB >> 35562621

Sex differences in serious adverse drug reactions in patients receiving immunotherapy, targeted therapy, or chemotherapy: a disproportionality analysis of the VigiBase®.

Guillaume Wabont1, Sandrine Bergeron2,3, Sophie Gautier2,3, Romain Barus2,3.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35562621     DOI： 10.1007/s00228-022-03332-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   3.064


× No keyword cloud information.
  3 in total

1.  Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.

Authors:  Jean-Louis Montastruc; Margaux Lafaurie; Claire de Canecaude; Geneviève Durrieu; Agnès Sommet; François Montastruc; Haleh Bagheri
Journal:  Br J Clin Pharmacol       Date:  2021-04-24       Impact factor: 4.335

2.  Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events.

Authors:  Yue Yu; Jun Chen; Dingcheng Li; Liwei Wang; Wei Wang; Hongfang Liu
Journal:  Sci Rep       Date:  2016-04-22       Impact factor: 4.379

3.  Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century.

Authors:  Sarah Watson; Ola Caster; Paula A Rochon; Hester den Ruijter
Journal:  EClinicalMedicine       Date:  2019-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.